Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic control through insulinotropic and anorectic effects. However, the role of adipokines and appetite-related hormones in mediating the glycemic response remains unclear. This study evaluated changes in abdominal fat, food cravings, and circulating adipokines and gut hormones following dulaglutide treatment and identified predictors of glycemic improvement in type 2 diabetes mellitus (T2DM).
Methods In this 24-week prospective observational study, 82 patients with T2DM and glycosylated hemoglobin (HbA1c) levels ≥7.0% despite standard therapy received dulaglutide 0.75 mg once weekly. Abdominal computed tomography, the General Food Cravings Questionnaire-Trait, and fasting levels of leptin, adiponectin, obestatin, ghrelin, and resistin were assessed at baseline and week 24. Glycemic responders were defined as those with an HbA1c reduction ≥0.5% and/or HbA1c <7.0% at 24 weeks. Multivariable regression analysis was performed to identify the factors associated with glycemic improvement.
Results Among the 67 patients who completed the study, dulaglutide significantly reduced HbA1c, food cravings, leptin, and adiponectin levels. Obestatin levels increased modestly. Responders showed greater improvement in β-cell function and more pronounced reductions in food cravings. In the adjusted models, a decrease in leptin and an increase in obestatin were independently associated with HbA1c reduction, while decreased adiponectin was associated with poorer glycemic outcomes. Changes in body mass index or abdominal fat were not associated with glycemic improvement.
Conclusion Dulaglutide improved glycemic control through mechanisms beyond weight reduction. Hormonal changes in leptin, adiponectin, and obestatin may help predict responses to GLP-1 RAs therapy.
Citations
Citations to this article as recorded by
Glucagon-like peptide-1 receptor agonists and tirzepatide are associated with reduced mortality, cardiovascular, and psychiatric risks in patients with hidradenitis suppurativa and type 2 diabetes and/or obesity: a retrospective cohort study Inga C. Brouer, Aida Zani, Henning Olbrich, Ralf J. Ludwig, Diamant Thaçi Frontiers in Medicine.2026;[Epub] CrossRef
Background Although the prevalence of diabetic kidney disease (DKD) is increasing, reliable biomarkers for its early detection are scarce. This study aimed to evaluate the association of adenosine and succinate levels and their related pathways, including hyaluronic acid (HA) synthesis, with DKD.
Methods We examined 235 participants and categorized them into three groups: healthy controls; those with diabetes but without DKD; and those with DKD, which was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. We compared the concentrations of urinary adenosine, succinate, and HA and the serum levels of cluster of differentiation 39 (CD39) and CD73, which are involved in adenosine generation, among the groups with DKD or albuminuria. In addition, we performed multiple logistic regression analysis to evaluate the independent association of DKD or albuminuria with the metabolites after adjusting for risk factors. We also showed the association of these metabolites with eGFR measured several years before enrollment. This study was registered with the Clinical Research Information Service (https://cris.nih.go.kr; Registration number: KCT0003573).
Results Urinary succinate and serum CD39 levels were higher in the DKD group than in the control and non-DKD groups. Correlation analysis consistently linked urinary succinate and serum CD39 concentrations with eGFR, albuminuria, and ΔeGFR, which was calculated retrospectively. However, among the various metabolites studied, only urinary succinate was identified as an independent indicator of DKD and albuminuria.
Conclusion Among several potential metabolites, only urinary succinate was independently associated with DKD. These findings hold promise for clinical application in the management of DKD.
Citations
Citations to this article as recorded by
Diabetic kidney disease: integrating multi-omics insights, artificial intelligence, and novel therapeutics for precision medicine Tao Li, Kaili Chen, Yiting Sun, Linqi Zhang Frontiers in Genetics.2026;[Epub] CrossRef
Spatial metabolomics: A new tool for unravelling the metabolic disorders and heterogeneity in diabetic kidney disease (Review) Hanfei Li, Yuxi Li, Bo Zhang, Wenhao Cheng, Guowei Ma, Jin Rong, Shiru Duan, Di Feng, Tingting Zhao International Journal of Molecular Medicine.2026; 57(4): 1. CrossRef
Next-Generation Redox Mediators: Itaconate, Nitro-Fatty Acids, Reactive Sulfur Species and Succinate as Emerging Switches in Predictive Redox Medicine Luca Gammeri, Alessandro Allegra, Fabio Stagno, Sebastiano Gangemi Antioxidants.2026; 15(4): 427. CrossRef
Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies Ziyue Zhang, Yilun Qu, Xiaochen Wang, Yuwei Ji, Jin Yao, Weizhu Deng, Guannan Sun, Hua Xu, Xiangmei Chen, Quan Hong Research.2026;[Epub] CrossRef
AI-assisted metabolomic profiling identifies candidate metabolites associated with diabetic kidney disease staging in a Korean cohort Inha Jung, Sungjin Park, Moongi Ji, So Young Park, Da Young Lee, Ji Hee Yu, Ji A. Seo, Man-Jeong Paik, Hyeong Kyu Park, Soon Hyo Kwon, Dae Ho Lee, Nan Hee Kim iScience.2026; 29(10): 117506. CrossRef
Trifolirhizin: A Phytochemical with Multiple Pharmacological Properties Varun Jaiswal, Hae-Jeung Lee Molecules.2025; 30(2): 383. CrossRef
The role of redox signaling in mitochondria and endoplasmic reticulum regulation in kidney diseases Omar Emiliano Aparicio-Trejo, Estefani Yaquelin Hernández-Cruz, Laura María Reyes-Fermín, Zeltzin Alejandra Ceja-Galicia, José Pedraza-Chaverri Archives of Toxicology.2025; 99(5): 1865. CrossRef
Chronic succinate exposure does not cause liver injury Joseph Balnis, Emily L. Jackson, Lisa A. Drake, Catherine E. Vincent, Hwajeong Lee, Harold A. Singer, Ariel Jaitovich American Journal of Physiology-Endocrinology and Metabolism.2025; 329(1): E39. CrossRef
Succinate Facilitates CD4+ T Cell Infiltration and CCL1 Production to Promote Myofibroblast Activation and Renal Fibrosis in UUO Mice Yuandong Tao, Wei Zhang, Dehong Liu, Hualin Cao, Xiaoyu Yi, Xiangling Deng, Pin Li, Xiaoli Shen, Huixia Zhou Journal of Inflammation Research.2025; Volume 18: 7827. CrossRef
From inflammation to healing: the crucial role of GPR91 activation and SDH inhibition in chronic diabetic wound recovery Hengdeng Liu, Shixin Zhao, Hanwen Wang, Xuefeng He, Suyue Gao, Minmin Su, Miao Zhen, Shuying Chen, Lei Chen, Julin Xie Stem Cell Research & Therapy.2025;[Epub] CrossRef
Network pharmacology and untargeted metabolomics reveal the mechanisms of Bushen Kaixuan Tongluo formula in diabetic kidney disease You Wang, Baosheng Zhao, Zhuqing Yang, Lingling Qin, Haiyan Wang, Cuiyan Lv, Tonghua Liu, Guangrui Huang Journal of Chromatography B.2025; 1265: 124752. CrossRef
Oxidative Stress, Metabolic Impairment and Neuroinflammation are Associated With Target Organ Damage in SHRSP S Hojná, L Mráziková, A Shánělová, H Pelantová, A Montezano, R Touyz, L Maletínská, J Kuneš Physiological Research.2025; : 779. CrossRef
It has been generally accepted that insulin resistance (IR) and reduced insulin secretory capacity are the basic pathogenesis of type 2 diabetes mellitus (T2DM). In addition to genetic factors, the persistence of systemic inflammation caused by obesity and the associated threat of lipotoxicity increase the risk of T2DM. In particular, the main cause of IR is obesity and subjects with T2DM have a higher body mass index (BMI) than normal subjects according to recent studies. The prevalence of T2DM with IR has increased with increasing BMI during the past three decades. According to recent studies, homeostatic model assessment of IR was increased compared to that of the 1990s. Rising prevalence of obesity in Korea have contributed to the development of IR, non-alcoholic fatty liver disease and T2DM and cutting this vicious cycle is important. My colleagues and I have investigated this pathogenic mechanism on this theme through clinical and experimental studies over 20 years and herein, I would like to summarize some of our studies with deep gratitude for receiving the prestigious 2023 Sulwon Award.
Citations
Citations to this article as recorded by
Recent Trends for Computational Enriched Diabetic Retinopathy Assessment: A Systematic Review Hrijuta Datta, Preity, Ashish Kumar Bhandari Archives of Computational Methods in Engineering.2026; 33(1): 1227. CrossRef
Macrophage Plg-RKT expression promotes diet-induced obesity and metabolic dysfunction-associated steatotic liver disease Lindsey A. Miles, Hongdong Bai, Sagarika Chakrabarty, Nagyung Baik, Yuqing Zhang, Robert J. Parmer, Fahumiya Samad Journal of Thrombosis and Haemostasis.2026; 24(1): 241. CrossRef
Attention-based graph neural network framework for non-invasive CAP score prediction in fatty liver disease via body modeling Ghasem Sadeghi Bajestani, Fatemeh Makhloughi, Ayoub Basham, Ebrahim Evazi, Mahdiyeh Razm Pour, Roohallah Alizadehsani, Farkhondeh Razmpour Physical and Engineering Sciences in Medicine.2026; 49(1): 183. CrossRef
Hepatorenal vulnerability flagged by glomerular hyperfiltration in metabolic liver disease: a large health-screening cohort evidence Dae-Jeong Koo, Yun Tae Kim, Sun-Joon Moon, Hyemi Kwon, Se Eun Park, Sang Min Lee, Cheol-Young Park, Won-Young Lee, Sung Rae Cho, Eun-Jung Rhee Diabetology & Metabolic Syndrome.2026;[Epub] CrossRef
Kudzu root-derived carbon dots modulate gut microbiota and metabolites for pan-organ targeted macrophage polarization in synergistic diabetes therapy Jianing Yi, Yuanyu Tang, Yilin Chen, Liang Chen, Dongxue Geng, Luyao Liu, Jie Yu, Lianhong Zou, Jie Zeng, Minhuan Lan, Wenjie Gao, Ming Gao Biomaterials.2026; 329: 123967. CrossRef
Development of a machine learning-based model for prediction of diabetes risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) Sijie Yang, Ruiqing Mo, Wenqiang Wang, Puxiang Zhen, Wentian Han BMJ Open.2026; 16(1): e107239. CrossRef
Liver fibrosis biomarkers as a prognostic tool beyond the defining components in cardiovascular-kidney-metabolic syndrome Zhenyang Cao, Binyan Chen, Jinghao Zhou, Jijie Jin, Dmitry Abramov, Shengzhang Chen, Pan Huang, Jianghua Zhou American Journal of Preventive Cardiology.2026; 26: 101438. CrossRef
Exploring the multifaceted roles of beta-defensins in prediabetes: a detailed review Nourah Almansour, Amal Hasan, Shaima Albeloushi, Rasheed Ahmad Frontiers in Endocrinology.2026;[Epub] CrossRef
Machine Learning–Based Prediction Model Construction for Type 2 Diabetes Mellitus: A Comparison of Algorithms and Multilevel Risk Factor Analysis Qian Xu, Ruicong Yu, Huixin Qiu, Yannan Jiang, Jake Ball, Cuirong Xu, Jing Sun, Weibing Ye Journal of Diabetes Research.2026;[Epub] CrossRef
Therapeutic potential of EGCG in treating vascular and metabolic disorders Zijian Li, Huifang Ge, Suowen Xu, Yijun Wang Journal of Functional Foods.2026; 140: 107284. CrossRef
Association Between Thyroid Hormone Sensitivity Indicators and Controlled Attenuation Parameter (CAP) Values in Euthyroid Adults with Overweight/Obesity Yifang Zhang, Cuiping Bao, Lingling Liu, Renjiao Liu, Xincheng Wang, Xiaoxuan Guo, Chunjun Li Diabetes, Metabolic Syndrome and Obesity.2026; Volume 19: 1. CrossRef
Impact of Fatty Liver Index on Cardiovascular Disease and Mortality across Alcohol Consumption Levels in Young Adults Byung-Hun Han, Joonyub Lee, Hun-Sung Kim, Jae-Hyoung Cho, Kyungdo Han, Seung-Hwan Lee Endocrinology and Metabolism.2026;[Epub] CrossRef
Thermosensitive TRP channels as dietary modulators of adipose thermogenesis: Implications for energy homeostasis and obesity Yashdeep Mukheja, Roshan Lal, Neha Soni, Jasleen Kaur, Pragyanshu Khare, Kanthi Kiran Kondepudi, Kanwaljit Chopra, Mahendra Bishnoi Journal of Thermal Biology.2026; 139: 104475. CrossRef
The Impact of Type 2 Diabetes Mellitus on Hepatic Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study Paula Mesquita, Cristiane Macedo, Ana Matos, Carla Henriques, Armando Carvalho, Adélia Simão GE - Portuguese Journal of Gastroenterology.2026; 33(1): 413. CrossRef
Borderline liver enzyme patterns and their metabolic–inflammatory signatures: an observational outpatient study Erdoğan Özdemir, Turgay Yılmaz Frontiers in Medicine.2026;[Epub] CrossRef
Sleep deprivation aggravates hepatocytes steatosis and insulin resistance by regulating exosomal microRNAs Xinxin Xu, Lulu Li, Ying Cao, Ying Wang, Chao Yang, Alexander Nikolaevich Orekhov, Yuanfeng Lu, Houbin Chu, Chuanrong Zhao, Guixue Wang, Guohua Song Interdisciplinary Medicine.2026;[Epub] CrossRef
Phytic Acid as a Functional Nutrient: Unraveling its Role in Type 2 Diabetes Management and Obesity Control Madhan Krishnan, Shyamaladevi Babu Molecular Nutrition & Food Research.2026;[Epub] CrossRef
Predictive performance of cardiometabolic indices for prediabetes progression to diabetes and reversion to normoglycemia in adults: a cohort study Yilin Zhu, Yangxuan He, Shusheng Fang, Hong Chen, Jingshan Jiang, Yunxiang Ming, Song Leng Frontiers in Nutrition.2026;[Epub] CrossRef
TIME-RESTRICTED EATING IN MASLD: THE IMPERATIVE TO PRESERVE MUSCLE MASS AND PREVENT WEIGHT CYCLING FOR SUSTAINABLE CLINICAL BENEFIT Yusuf Bünyamin KETENCİ, Hakan DEMİRÖZ, Mehmet AKCA Arquivos de Gastroenterologia.2026;[Epub] CrossRef
Global, regional and national burden and trends of non-alcoholic fatty liver disease in women of reproductive age from 1990 to 2021: Insights from the Global burden of disease study 2021 Yi Yu, Chunxia Zhang, Zirong Liang, Xiang Wang, Jun Wang, Feihu Bai, Dekui Zhang, Yonggang Tian Indian Journal of Gastroenterology.2026;[Epub] CrossRef
DN203316, a novel PPARδ agonist, suppresses ferroptotic signaling and fibrogenesis in metabolic dysfunction-associated steatohepatitis Ye Jin Kim, Jina Kim, Da Young An, Mihyang Park, Gui-Hwa Jeong, Jonghwa Jin, Mi Kyung Kim, Jungwook Chin, Yeon-Kyung Choi, Keun-Gyu Park Experimental & Molecular Medicine.2026; 58(6): 1900. CrossRef
Elevated homocysteine levels are associated with increased diabetes risk in patients with hypertension: a multicenter longitudinal study Ya He, Xianwei Tian, Chenru Zhao, Meng Chen, Hongyan Zhang Frontiers in Cardiovascular Medicine.2026;[Epub] CrossRef
Adipose tissue distribution in metabolic disease: depot-specific biology, clinical assessment, and therapeutic remodeling Anke LiuLi, Tongtong Zhang, Zhonghui Feng Frontiers in Endocrinology.2026;[Epub] CrossRef
Extracellular vesicles from steatotic hepatocytes promote endothelial dysfunction and atherogenesis via miR-30b-5p/ELOVL5 axis Marie Rhee, Joonyub Lee, Cheol Woon Jung, Jinsung Yang, Won Gun Choi, Young-Hye You, Heon-Seok Park, Eun Young Lee, Eun Kyung Lee, Sung Won Kwon, Young-Bum Kim, Seung-Hwan Lee Molecular Therapy.2026; 34(9): 5382. CrossRef
Tissue-Specific Transcriptomics Uncover Exercise-Responsive Immune–Metabolic Regulatory Targets in Obesity Yingfeng Chen, Renqing Zhao, Ji Ma, Weidong Zheng, Jian Gong Metabolites.2026; 16(7): 472. CrossRef
Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective Soo Lim, Seung-Hwan Lee, Robert H. Eckel Diabetes & Metabolism Journal.2026; 50(4): 641. CrossRef
Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study Yanqiu Huang, Yadan Xu, Chenghao Zhang, Wen Gu, Yue Li, Haojia Zhang, Tian Wang, Tangyi Su, Yangchen Lhamu, Yichen Chen, Liang Zhou, Lipeng Hao, Yang Yang, Hui Wang Cardiovascular Diabetology.2026;[Epub] CrossRef
Routine biochemical indices for hepatometabolic stratification across the dysglycaemia spectrum: insulin resistance, fibrosis scores, and machine-learning integration Pedro Villafruela-Rodríguez-Manzaneque, Jordi Tortosa-Carreres, Antonio Sierra-Rivera, Manuela Morales-Garcés, Laura Sahuquillo-Frias, Goitzane Marcaida-Benito Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.2026; 7(3): 211. CrossRef
Expression profiles of selected circulating microRNAs (miR-192-5p and miR-155-3p) in NAFLD and their association with obesity and type 2 diabetes mellitus Rana Mohamed, Mohamed M. Sadaty, Emad El-Zayat, Sahar H. Ahmed, Mohamed Awadein, Nahla O. Mousa Acta Diabetologica.2026;[Epub] CrossRef
Icariin-loaded liposomal nanoparticles alleviate streptozotocin-induced diabetic hepatopathy associated with modulation of ferroptosis-related and inflammatory signaling Badriah A. Hifni, Shaza A. Alyamani, Nasser S. Alqahtani, Ayat B. Al-Ghafari, Huda A. Al Doghaither, Ekramy M. Elmorsy, Manal S. Fawzy, Gehad E. Elshopakey BMC Pharmacology and Toxicology.2026;[Epub] CrossRef
Physical activity and type 2 diabetes risk Jing Liu, Qingtao Zeng Medicine.2026; 105(36): e50570. CrossRef
Therapeutic Potential of Gene‐Modified MSC‐Exos in Insulin Resistance: Mitochondrial Crosstalk and miRNA Regulation Qinghua Jia, Bing Li, Yuan Xing, Yuanyuan Zhang, Baodong Gao, Xiangying Li, Xiaoqin Ha Journal of Cellular and Molecular Medicine.2026;[Epub] CrossRef
Advances in the application of insulin resistance-related indicators in the clinical evaluation of metabolic dysfunction-associated steatotic liver disease Yi Li, Huan Li, Bolun Zhang, Qingming Wu, Hui Long Frontiers in Gastroenterology.2026;[Epub] CrossRef
Development and validation of a risk model for non-fatty chronic liver disease in middle-aged and older adults with metabolic syndrome Xiumei Zhou, Xiaoxin Wu, Lingxiao Jin, Xuhong Zhao, Qiaozhen Zhang, Junfeng Yin BMC Gastroenterology.2026;[Epub] CrossRef
γ-Glutamylcysteine restores glucolipotoxicity-induced islet β-cell apoptosis and dysfunction via inhibiting endoplasmic reticulum stress Jinyi Zhou, Yingying Shi, Lishuang Zhao, Rong Wang, Lan Luo, Zhimin Yin Toxicology and Applied Pharmacology.2025; 495: 117206. CrossRef
Comparison of SPISE and METS-IR and Other Markers to Predict Insulin Resistance and Elevated Liver Transaminases in Children and Adolescents Kyungchul Song, Eunju Lee, Hye Sun Lee, Hana Lee, Ji-Won Lee, Hyun Wook Chae, Yu-Jin Kwon Diabetes & Metabolism Journal.2025; 49(2): 264. CrossRef
Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions Mohammad Muzaffar Mir, Mohammed Jeelani, Muffarah Hamid Alharthi, Syeda Fatima Rizvi, Shahzada Khalid Sohail, Javed Iqbal Wani, Zia Ul Sabah, Waad Fuad BinAfif, Partha Nandi, Abdullah M. Alshahrani, Jaber Alfaifi, Adnan Jehangir, Rashid Mir International Journal of Molecular Sciences.2025; 26(6): 2770. CrossRef
Investigating the Effects of Gossypetin on Liver Health in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats Karishma Naidoo, Andile Khathi Molecules.2025; 30(8): 1834. CrossRef
Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study Ziping Song, Xinlei Miao, Shuang Liu, Manling Hu, Xiaoling Xie, Yuting Sun, Song Leng Cardiovascular Diabetology.2025;[Epub] CrossRef
Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice Darya Ivashkevich, Arina Ponomarenko, Igor Manzhulo, Anastasia Egoraeva, Inessa Dyuizen Pathophysiology.2025; 32(2): 16. CrossRef
Extracellular Vesicle-Mediated Network in the Pathogenesis of Obesity, Diabetes, Steatotic Liver Disease, and Cardiovascular Disease Joonyub Lee, Won Gun Choi, Marie Rhee, Seung-Hwan Lee Diabetes & Metabolism Journal.2025; 49(3): 348. CrossRef
Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes Zhixing Fan, Chaojun Yang, Xiaojing Zhao, Jing Zhang Scientific Reports.2025;[Epub] CrossRef
The Triglyceride-Glucose Index and Risk of End-Stage Renal Disease across Different Durations of Type 2 Diabetes Mellitus: A Longitudinal Cohort Study Mi-sook Kim, Kyu-Na Lee, Jeongmin Lee, Jeongeun Kwak, Seung-Hwan Lee, Hyuk-Sang Kwon, Jing Hughes, Kyung-Do Han, Eun Young Lee Endocrinology and Metabolism.2025; 40(5): 718. CrossRef
Tectoridin modulates intertwined molecular pathways in metabolic syndrome: insights from network pharmacology, molecular docking, and in vivo studies Ashwini Kumar Mishra, Pravat Kumar Sahoo, Rajesh Singh, Smita Jain Inflammopharmacology.2025; 33(9): 5545. CrossRef
Triglyceride–Glucose-Based Anthropometric Indices for Predicting Incident Cardiovascular Disease: Relative Fat Mass (RFM) as a Robust Indicator Xinlei Chu, Haozhi Niu, Ning Wang, Yu Wang, Hongkai Xu, Huiying Wang, Liting Wu, Wei Li, Lei Han Nutrients.2025; 17(13): 2212. CrossRef
Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park Cardiovascular Diabetology.2025;[Epub] CrossRef
Associations between the effectiveness of sleeve gastrectomy and the composition and function of gut microbiome in obese rats Yifan Cao, Songhan Qin, Dandan Liu, Tao Zhang, Yin Wu, Ming Xie, Jiwei Wang Journal of Gastrointestinal Surgery.2025; 29(9): 102153. CrossRef
Exercise Interventions for Metabolic Diseases: An Analysis of the Evolution of Aerobic Exercise Bibliometrics in the Field of Type 2 Diabetes Mellitus Yang Li, Amin Ullah, Shuhao Fang, Donglin Liu, Zhenwei Cui, Guangning Kou Healthcare.2025; 13(17): 2087. CrossRef
Association Between Depression and Hepatic Steatosis According to Obese Status: The Korean National Health and Nutrition Examination Survey 2010–2019 Young Sang Lyu, Youngmin Yoon, Jin Hwa Kim, Sang Yong Kim Medicina.2025; 61(9): 1711. CrossRef
Serum Granulin Concentrations Are Elevated in Prediabetes and Newly Diagnosed Diabetes: A Cross-Sectional Study Yu-Hsuan Chou, Yuan Kao, Ka Chon Chan, Hsuan-Wen Chou, Yu-Cheng Liang, Hung-Tsung Wu, Horng-Yih Ou Journal of Clinical Medicine.2025; 14(18): 6566. CrossRef
Mechanistic Insights into N-Oleoylethanolamide-Mediated Hepatoprotection via PPAR-α Darya Ivashkevich, Arina Ponomarenko, Igor Manzhulo, Inessa Dyuizen BIOCELL.2025; 49(4): 607. CrossRef
Clinical Implementation of Sustainable Functional Foods and Nutraceuticals in Metabolic Health: A Feasibility Study Francesca Scionti, Samantha Maurotti, Elisa Mazza, Angela Mirarchi, Raffaella Russo, Paola Doria, Rosario Mare, Giuseppe Marafioti, Yvelise Ferro, Tiziana Montalcini, Arturo Pujia Nutrients.2025; 17(24): 3858. CrossRef
The association of multiple metabolic disorders with the severity of fasting blood glucose and hepatic steatosis in a Chinese population with MAFLD: a cross-sectional study of over 3000 participants Xue Qu, Shanshan Jin, Yuqing Shi, Weisong Zhang, Delong Cong, Yangyang Liu Scientific Reports.2025;[Epub] CrossRef
Frequency and Association of Dyslipidemia with Clinical and Biochemical Parameters among Patients with Non-alcoholic Fatty Liver Disease Arslan Ahmad, Shazia Siddique, Amanullah Bhalli, Amina Umer, Umayma Asad, Muhammad Irfan Jamil Pakistan Journal of Health Sciences.2025; : 75. CrossRef
Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM rats Haoru Duan, Shanshan Song, Rui Li, Suqin Hu, Shuting Zhuang, Shaoyang liu, Xiaolu Li, Wei Gao Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won- Diabetes & Metabolism Journal.2024; 48(6): 1015. CrossRef
Da Young Lee, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim
Diabetes Metab J. 2024;48(1):37-52. Published online January 3, 2024
Novel strategies are required to reduce the risk of developing diabetes and/or clinical outcomes and complications of diabetes. In this regard, the role of the circadian system may be a potential candidate for the prevention of diabetes. We reviewed evidence from animal, clinical, and epidemiological studies linking the circadian system to various aspects of the pathophysiology and clinical outcomes of diabetes. The circadian clock governs genetic, metabolic, hormonal, and behavioral signals in anticipation of cyclic 24-hour events through interactions between a “central clock” in the suprachiasmatic nucleus and “peripheral clocks” in the whole body. Currently, circadian rhythmicity in humans can be subjectively or objectively assessed by measuring melatonin and glucocorticoid levels, core body temperature, peripheral blood, oral mucosa, hair follicles, rest-activity cycles, sleep diaries, and circadian chronotypes. In this review, we summarized various circadian misalignments, such as altered light-dark, sleep-wake, rest-activity, fasting-feeding, shift work, evening chronotype, and social jetlag, as well as mutations in clock genes that could contribute to the development of diabetes and poor glycemic status in patients with diabetes. Targeting critical components of the circadian system could deliver potential candidates for the treatment and prevention of type 2 diabetes mellitus in the future.
Citations
Citations to this article as recorded by
Late-eating adolescents consume more energy, make poorer dietary choices, and are more likely to have excess weight: An analysis of the Brazilian Household Budget Survey (2008–2009) Maria Carliana Mota, Laura Cristina Tibiletti Balieiro, Luana Thomazetto Rossato, Claudia Roberta de Castro Moreno, Cibele Aparecida Crispim Chronobiology International.2026; 43(1): 104. CrossRef
Unraveling the Tapestry of Health: The Intricate Dance of Circadian Rhythms and Human Diseases Sidrah Parvez, Andrej Dzupina, Ghizal Fatima, Najah Hadi, Jan Fedacko, Aminat Magomedova, Ammar Mehdi Raza, Nasser Ghaly Yousif, Hekmat B. Alhmadi Bratislava Medical Journal.2026; 127(2): 492. CrossRef
Diabetes and its complications: molecular mechanisms, prevention and treatment Lijun Zhao, Jiamin Yuan, Qing Yang, Jing Ma, Fenghao Yang, Yutong Zou, Ke Liu, Fang Liu Signal Transduction and Targeted Therapy.2026;[Epub] CrossRef
Prediabetes is a window of opportunity for preventive interventions. Part 2 T. V. Adasheva, E. E. Gubernatorova, E. I. Fomina, E. G. Lobanova Meditsinskiy sovet = Medical Council.2026; (23): 123. CrossRef
Association of daytime circadian-aligned activity with glycemic control in type 2 diabetes: Insights from continuous glucose monitoring and wearable data Da Young Lee, Jung-Been Lee, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Heon-Jeong Lee, Nan Hee Kim Metabolism.2026; 179: 156570. CrossRef
Applying AI Tools for Monitoring Nutrition and Physical Activity in Populations with Obesity: Are We Ready? Alessandra Amato, Sara Baldassano, Giuseppe Musumeci Obesities.2026; 6(2): 19. CrossRef
PERSONALIZED CHRONOTHERAPY: BRIDGING PRECISION MEDICINE WITH CIRCADIAN THERAPEUTICS Rajeswari Aleti, Monika Nijhawan, Mohammad Bakhatwar, Srinivas Baratam, Krishna Kishore Adireddy INDIAN DRUGS.2026; 63(03): 8. CrossRef
Humidity as a potential zeitgeber for circadian entrainment of insect systems Shyh-Chi Chen, Grace Goodhart, Daniel Eaton, Nathan Catlett, Tabitha Cady, Hannah Tran, Luke E. Lutz, Lyn Wang, Ella Girard, Jaida Savino, Jodi Perry, Libby Coen, Leo Walker, Amena Bidiwala, Emma Tarter, Joshua Tompkin, Nina Greene, Aiden Yang, Joshua B. npj Biological Timing and Sleep.2026;[Epub] CrossRef
Management of Obstructive Sleep Apnea in People with Type 2 Diabetes Niel Patel, Miriam Soliman, Amit Majithia, Atul Malhotra Diabetology.2026; 7(7): 128. CrossRef
Diversity of Daily Glycemic Phenotypes Is Independently Associated With HbA1c: A Time-Resolved CGM Clustering Analysis Saeko Osawa, Emi Kuroiwa, Naohiko Ito Journal of Diabetes Science and Technology.2026;[Epub] CrossRef
Circadian Misalignment and Chrononutrition in Type 2 Diabetes: Mechanistic Insights and Translational Gaps İsmail Celil Haskoloğlu, Zeynep Güneş Özünal International Journal of Molecular Sciences.2026; 27(19): 8473. CrossRef
Chrononutrition: Potential, Challenges, and Application in Managing Obesity Siti Aisyah Fuad, Rehna Paula Ginting, Min-Woo Lee International Journal of Molecular Sciences.2025; 26(11): 5116. CrossRef
Chrononutrition and Energy Balance: How Meal Timing and Circadian Rhythms Shape Weight Regulation and Metabolic Health Claudia Reytor-González, Daniel Simancas-Racines, Náthaly Mercedes Román-Galeano, Giuseppe Annunziata, Martina Galasso, Raynier Zambrano-Villacres, Ludovica Verde, Giovanna Muscogiuri, Evelyn Frias-Toral, Luigi Barrea Nutrients.2025; 17(13): 2135. CrossRef
Chronic stress, gut microbiota, and immunity: interconnections and implications for health Hexiao Jia, Xiaodong Guo, Yihong Wei, Can Can, Na He, Hailei Zhang, Xinyu Yang, Hanyang Wu, Wancheng Liu, Daoxin Ma Molecular and Cellular Biochemistry.2025; 480(12): 5995. CrossRef
Chrononutrition and sleep patterns in individuals with diabetes mellitus: Assessing misalignments and social jetlag Micaela Rabelo Quadra, Fernanda Olivera Meller, Antônio Augusto Schäfer, Taísa Dimer Hendler, Emilio Luiz Streck Chronobiology International.2025; 42(10): 1427. CrossRef
Effects of time-restricted eating on body composition and metabolic parameters in overweight and obese women: a systematic review and meta-analysis Shiying Chen, Xiaotian Zhang, Jakub Kortas, Haitao Liu Frontiers in Nutrition.2025;[Epub] CrossRef
The oncogenic role of BMAL2 in non-small cell lung cancer: MRPL15-mediated regulation of apoptosis and ferroptosis Yang Liu, Yixia Li, Xiaotian Zhai, Lei Yang, Jie Li, Yi Han Translational Oncology.2025; 62: 102560. CrossRef
Circadian Rhythm: Biological Functions, Diseases, and Therapeutic Targets Kangkang Zha, Bobin Mi, Yuan Xiong, Shuyan Wu, Li Lu, Shengming Zhang, Xuan Lu, Hei Chung Mak, Jianping Huang, Adriana C. Panayi, Samuel Knoedler, Lili Chen, Guohui Liu, Sien Lin MedComm.2025;[Epub] CrossRef
Da Young Lee, Namho Kim, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Jihee Kim, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Sung-Min Park, Nan Hee Kim
Diabetes Metab J. 2023;47(6):826-836. Published online August 24, 2023
Background There was limited evidence to evaluate the association between lifestyle habits and continuous glucose monitoring (CGM) metrics. Thus, we aimed to depict the behavioral and metabolic determinants of CGM metrics in insulin-treated patients with type 2 diabetes mellitus (T2DM).
Methods This is a prospective observational study. We analyzed data from 122 insulin-treated patients with T2DM. Participants wore Dexcom G6 and Fitbit, and diet information was identified for 10 days. Multivariate-adjusted logistic regression analysis was performed for the simultaneous achievement of CGM-based targets, defined by the percentage of time in terms of hyper, hypoglycemia and glycemic variability (GV). Intake of macronutrients and fiber, step counts, sleep, postprandial C-peptide-to-glucose ratio (PCGR), information about glucose lowering medications and metabolic factors were added to the analyses. Additionally, we evaluated the impact of the distribution of energy and macronutrient during a day, and snack consumption on CGM metrics.
Results Logistic regression analysis revealed that female, participants with high PCGR, low glycosylated hemoglobin (HbA1c) and daytime step count had a higher probability of achieving all targets based on CGM (odds ratios [95% confidence intervals] which were 0.24 [0.09 to 0.65], 1.34 [1.03 to 1.25], 0.95 [0.9 to 0.99], and 1.15 [1.03 to 1.29], respectively). And participants who ate snacks showed a shorter period of hyperglycemia and less GV compared to those without.
Conclusion We confirmed that residual insulin secretion, daytime step count, HbA1c, and women were the most relevant determinants of adequate glycemic control in insulin-treated patients with T2DM. In addition, individuals with snack consumption were exposed to lower times of hyperglycemia and GV.
Citations
Citations to this article as recorded by
Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinion Soo Lim, Rimei Nishimura, Jothydev Kesavadev, Alice Pik Shan Kong, Margaret J McGill, Horng-Yih Ou, Chun-Kwan O, Chun-Chuan Lee, Xiaomei Zhang, Linong Ji, Chih-Yuan Wang Diabetes Research and Clinical Practice.2026; 233: 113054. CrossRef
Association of daytime circadian-aligned activity with glycemic control in type 2 diabetes: Insights from continuous glucose monitoring and wearable data Da Young Lee, Jung-Been Lee, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Heon-Jeong Lee, Nan Hee Kim Metabolism.2026; 179: 156570. CrossRef
Accelerometer-Derived Physical Activity, Sedentary Behavior, and Continuous Glucose Monitoring-Derived Glycemic Variability in Adults with Type 2 Diabetes: A Longitudinal Repeated-Measures Study Paul César Velásquez Porras, Alicia Olinda Neyra Aranda, Dimna Zoila Alfaro Quezada, Digmer Pablo Riquez Livia, Henri Emmanuel Lopez Gomez, Roberto Carlos Dávila-Morán Journal of Functional Morphology and Kinesiology.2026; 11(3): 338. CrossRef
Clinical, genetic, and proteomic characteristics of type 2 diabetes complicated with exogenous insulin antibody syndrome: a case-control study Jinjing Wan, Leiluo Geng, Yiwen Fu, Qianting Zhang, Gaopeng Guan, Xue Jiang, Aimin Xu, Ping Jin Diabetes Research and Clinical Practice.2025; 225: 112262. CrossRef
Expanding the Use of Continuous Glucose Monitoring in Type 2 Diabetes Mellitus: Impact on Glycemic Control and Metabolic Health Mi-Joon Lee, Bum-Jeun Seo, Jae-Hyoung Cho Life.2025; 15(10): 1543. CrossRef
Explanatory variables of objectively measured 24-h movement behaviors in people with prediabetes and type 2 diabetes: A systematic review Lotte Bogaert, Iris Willems, Patrick Calders, Eveline Dirinck, Manon Kinaupenne, Marga Decraene, Bruno Lapauw, Boyd Strumane, Margot Van Daele, Vera Verbestel, Marieke De Craemer Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(4): 102995. CrossRef
Background Exercise is recommended for type 2 diabetes mellitus (T2DM) patients to prevent cardiovascular disease. However, the effects of physical activity (PA) for reducing the risk of heart failure (HF) has yet to be elucidated. We aimed to assess the effect of changes in patterns of PA on incident HF, especially in newly diagnosed diabetic patients.
Methods We examined health examination data and claims records of 294,528 participants from the Korean National Health Insurance Service who underwent health examinations between 2009 and 2012 and were newly diagnosed with T2DM. Participants were classified into the four groups according to changes in PA between before and after the diagnosis of T2DM: continuously inactive, inactive to active, active to inactive, and continuously active. The development of HF was analyzed until 2017.
Results As compared with those who were continuously inactive, those who became physically active after diagnosis showed a reduced risk for HF (adjusted hazard ratio [aHR], 0.79; 95% confidence interval [CI], 0.66 to 0.93). Those who were continuously active had the lowest risk for HF (aHR, 0.77; 95% CI, 0.62 to 0.96). As compared with those who were inactive, those who exercised regularly, either performing vigorous or moderate PA, had a lower HF risk (aHR, 0.79; 95% CI, 0.69 to 0.91).
Conclusion Among individuals with newly diagnosed T2DM, the risk of HF was reduced in those with higher levels of PA after diagnosis was made. Our results suggest either increasing or maintaining the frequency of PA after the diagnosis of T2DM may lower the risk of HF.
Citations
Citations to this article as recorded by
Global, regional, and national burden of major diabetes-related complications attributable to physical inactivity Jayne Feter, Natan Feter, Rodrigo Leal-Menezes, Pedro C. Hallal, Daniel Umpierre Journal of Sport and Health Science.2026; 15: 101123. CrossRef
Does physical activity reduce cardiovascular risk associated with knee osteoarthritis in type 2 diabetes? A nationwide cohort study Dojoon Park, Kyuho Kim, Hae-Seok Koh, Kyungdo Han, Youn-Ho Choi The Korean Journal of Internal Medicine.2026; 41(3): 485. CrossRef
2026 ESC Guidelines for the management of heart failure Lars Køber, Marianna Adamo, Anne-Christine Ruwald, Daniela Tomasoni, Lisa J Anderson, Charlotte Andersson, Jasper J Brugts, Ovidiu Chioncel, Erwan Donal, Peter Ferdinandy, Pardeep S Jhund, Francisco Leyva, Roberto Lorusso, Michael Madigan, Wilfried Mullen European Heart Journal.2026; 47(38): 5346. CrossRef
Life-course obesity and heart failure: a two-sample Mendelian randomization study Haili Wang, Jie Min, Lei Zhong, Jinyu Zhang, Lili Ye, Chunrong Chen Internal and Emergency Medicine.2025; 20(1): 171. CrossRef
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives Elina Khattab, Michaelia Kyriakou, Elena Leonidou, Stefanos Sokratous, Angeliki Mouzarou, Michael M. Myrianthefs, Nikolaos P. E. Kadoglou Pharmaceuticals.2025; 18(1): 134. CrossRef
Sitagliptin, diabetes mellitus, and heart failure: an in-depth review of sitagliptin therapy and heart failure in patients with diabetes mellitus Mohammadjavad Sotoudeheian, Seyed-Mohamad-Sadegh Mirahmadi, Pedram Salehi Darjani, Mohammad Moradi, Mohammad Pirhayati, Mohammad Sedigh Dakkali, Mehdi Taghizadeh, Reza Azarbad, Hamidreza Pazoki Toroudi Diabetology International.2025; 16(2): 237. CrossRef
Exploring the Lack of Physical Activity among Adolescents Worldwide Dalmacito A. Cordero Jr. Diabetes & Metabolism Journal.2025; 49(3): 513. CrossRef
Physical activity for prevention of cardiovascular disease: consensus statement of Korean Society of Cardio-cerebrovascular Disease Prevention Ye Seul Yang, Eu Jeong Ku, Seung-Hyun Ko, Eun-Jung Rhee, Sang-Hyun Ihm, Sung Hee Choi, Won-Young Lee The Korean Journal of Internal Medicine.2025; 40(5): 696. CrossRef
Physical activity for prevention of cardiovascular disease: a consensus statement of the Korean Society of Cardio-cerebrovascular Disease Prevention Ye Seul Yang, Eu Jeong Ku, Seung-Hyun Ko, Eun-Jung Rhee, Sang-Hyun Ihm, Sung Hee Choi, Won-Young Lee Cardiovascular Prevention and Pharmacotherapy.2025; 7(4): 120. CrossRef
Associations Between Physical Activity and the Risk of Hip Fracture Depending on Glycemic Status: A Nationwide Cohort Study Kyoung Min Kim, Kyoung Jin Kim, Kyungdo Han, Yumie Rhee The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1194. CrossRef
Association between exercise habits and incident type 2 diabetes mellitus in patients with thyroid cancer: nationwide population-based study Jiyun Park, Jin-Hyung Jung, Hyunju Park, Young Shin Song, Soo-Kyung Kim, Yong-Wook Cho, Kyungdo Han, Kyung-Soo Kim BMC Medicine.2024;[Epub] CrossRef
Dose-Response Relationship Between Physical Activity and the Morbidity and Mortality of Cardiovascular Disease Among Individuals With Diabetes: Meta-Analysis of Prospective Cohort Studies Yang Chen, Xingsheng Jin, Guochong Chen, Ru Wang, Haili Tian JMIR Public Health and Surveillance.2024; 10: e54318. CrossRef
Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon International Journal of Heart Failure.2023; 5(1): 1. CrossRef
Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon Diabetes & Metabolism Journal.2023; 47(1): 10. CrossRef
Association of plasma brain-derived neurotrophic factor levels and frailty in community-dwelling older adults Eun Roh, Soon Young Hwang, Eyun Song, Min Jeong Park, Hye Jin Yoo, Sei Hyun Baik, Miji Kim, Chang Won Won, Kyung Mook Choi Scientific Reports.2022;[Epub] CrossRef
The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study Jiyun Park, Gyuri Kim, Hasung Kim, Jungkuk Lee, Sang-Man Jin, Jae Hyeon Kim Cardiovascular Diabetology.2022;[Epub] CrossRef
Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to maintain optimal glycemic control are often challenging for T1DM patients and their families because they require frequent blood glucose checks. In recent years, technological advances in insulin pumps and continuous glucose monitoring systems have created paradigm shifts in T1DM care that are being extended to develop artificial pancreas systems (APSs). Numerous studies that demonstrate the superiority of glycemic control offered by APSs over those offered by conventional treatment are still being published, and rapid commercialization and use in actual practice have already begun. Given this rapid development, keeping up with the latest knowledge in an organized way is confusing for both patients and medical staff. Herein, we explore the history, clinical evidence, and current state of APSs, focusing on various development groups and the commercialization status. We also discuss APS development in groups outside the usual T1DM patients and the administration of adjunct agents, such as amylin analogues, in APSs.
Citations
Citations to this article as recorded by
Unlocking Real-Time Data Access in Diabetes Management: Toward an Interoperability Model Pietro Randine, Miriam Kopperstad Wolff, Matthias Pocs, Ian R. O. Connell, Joseph A. Cafazzo, Eirik Årsand Journal of Diabetes Science and Technology.2026; 20(5): 1565. CrossRef
Real-World Outcomes of Hybrid Closed-Loop System Use in Korean Youth With Childhood-Onset Type 1 Diabetes Hyun Ah Woo, Su Jin Jeong, Yun Jeong Lee, Hwa Young Kim, Minjeong Gu, Ji Young Kim, Jaehyun Kim, Choong Ho Shin, Young Ah Lee Journal of Korean Medical Science.2026;[Epub] CrossRef
Neuromodulation using Bioelectronics-enabled therapies to combat insulin resistance and its comorbidities Yosra Magdi Mekki, Jeongeun Park, Zeinah Alzaareer, Zaeem Hussain, Ayesha Gulzar, Abdelnaser Elzouki, Amparo Güemes, Susu M. Zughaier Journal of Diabetes & Metabolic Disorders.2026;[Epub] CrossRef
Computational physiological models for hemodynamic management in critical care: a systematic literature review focusing on model design, credibility and clinical readiness M.P. Mulder, R.S.P. Warnaar, T.F. Arendshorst-Ruuls, L.M. van Loon, C.L. Meuwese, M. Broomé, E. Oppersma, D.W. Donker, L. Fresiello Computers in Biology and Medicine.2026; 205: 111561. CrossRef
Automated insulin delivery in young children with type 1 diabetes: a systematic review and meta-analysis Puguh Oktavian, Citrawati Dyah Kencono Wungu, Indah Mohd Amin, Sony Wibisono Mudjanarko The Journal of Clinical Endocrinology & Metabolism.2026; 111(8): e2043. CrossRef
GluPatchNet: A Channel-Mixed and decomposition-based blood glucose prediction scheme for mitigating CGM time delay Su-Jin Kim, Sungho Kim, Jun Sung Moon, Sung-Yoon Jung ICT Express.2026; 12(3): 746. CrossRef
Pancreas transplantation: Radiological assessment of surgical techniques and potential complications A. Berasategui Criado, S. Cayón Somacarrera, R. Pellón Daben, F.J. González Sánchez, J.A. Echeverri Cifuentes, J. Crespo del Pozo Radiología (English Edition).2026; : 501696. CrossRef
To be, or not to be, on insulin for simultaneous kidney-pancreas transplant: Is that the question? Robert J. Stratta, Alan C. Farney, Jonathan A. Fridell American Journal of Transplantation.2026;[Epub] CrossRef
Metabolic Responses to Exercise and Nutritional Strategies in Type 1 Diabetes Using Automated Insulin Delivery Systems: A Narrative Review Desirée Victoria-Montesinos, Inmaculada Llopis-Alonso, Ana María García-Muñoz, María Teresa Mercader-Ros Metabolites.2026; 16(7): 437. CrossRef
Long-term effectiveness of automated insulin delivery in young people with type 1 diabetes: a meta-analysis Zhihui Sun, Sihan Yang, Le Gao, Lin Dou, Baoqi Zeng Diabetology & Metabolic Syndrome.2026;[Epub] CrossRef
Artificial intelligence in medicine: a clinician-oriented guide and operational framework to evaluate new AI devices Gabriel Szydlo Shein, Serban C. Tudosie, Stefan M. Jensen, Ronit Brodie, Sylvain Lecler, Michele Diana, Yoav Mintz Minimally Invasive Therapy & Allied Technologies.2026; : 1. CrossRef
Artificial Pancreas and Closed-Loop Insulin Delivery: From Early Concepts to AI-Driven Diabetes Automation Reem Emad Al-Dhaleai, Mustafa Tariq Khan, Zaid Chilmeran, Abdulrahman Husain AlSadeq, Alexandra E. Butler Biosensors.2026; 16(9): 507. CrossRef
Smart Pharmaceutical Systems: Sensor-Enabled Delivery, Feedback Control, and Therapeutic Autonomy Ahmed Benali, Karim Boudiaf, Samir Touati Journal of Applied Pharmaceutical Technologies and Systems.2026;[Epub] CrossRef
Implantable Fluorogenic DNA Biosensor for Stress Detection Irina Drachuk, Namrata Ramani, Svetlana Harbaugh, Chad A. Mirkin, Jorge L. Chávez ACS Applied Materials & Interfaces.2025; 17(1): 130. CrossRef
CHoKI-based MPC for blood glucose regulation in Artificial Pancreas Beatrice Sonzogni, José María Manzano, Marco Polver, Fabio Previdi, Antonio Ferramosca IFAC Journal of Systems and Control.2025; 31: 100294. CrossRef
Automated insulin delivery in pregnant women with type 1 diabetes: a systematic review and meta-analysis Qin Yang, Jiayi Hao, Huijing Cui, Qingqing Yang, Feng Sun, Baoqi Zeng Acta Diabetologica.2025; 62(8): 1325. CrossRef
Designing and developing a prescription digital therapeutic for at-home heart rate variability biofeedback to support and enhance patient outcomes in post-traumatic stress disorder treatment Rebecca Macy, Flavio Somanji, Oleksandr Sverdlov Frontiers in Digital Health.2025;[Epub] CrossRef
Generalized reinforcement learning control algorithm for fully automated insulin delivery system Vega Pradana Rachim, Junyoung Yoo, Jaeyeon Lee, Yein Lee, Sung-Min Park Expert Systems with Applications.2025; 274: 126909. CrossRef
Allogeneic Islet Transplantation: Chronicle of a Death Foretold? Thierry Berney, Olivier Thaunat, Ekaterine Berishvili Transplant International.2025;[Epub] CrossRef
Exogenous vs Endogenous Insulin Delivery: 2025 Ankita Patel, Rachel Todd, Nina L. Owen-Simon, Kasi McCune Current Transplantation Reports.2025;[Epub] CrossRef
Long-term blood glucose prediction using deep learning-based noise reduction Su-Jin Kim, Jun Sung Moon, Sung-Yoon Jung ICT Express.2025; 11(4): 715. CrossRef
Trasplante de páncreas: evaluación radiológica de las técnicas quirúrgicas y potenciales complicaciones A. Berasategui Criado, S. Cayón Somacarrera, R. Pellón Daben, F.J. González Sánchez, J.A. Echeverri Cifuentes, J. Crespo del Pozo Radiología.2025; : 501696. CrossRef
Nano-based therapy for type 1 diabetes: from immuno-intervention to insulin delivery Huiwen Pang, Zhuo Chen, Felicity Y. Han Acta Biomaterialia.2025; 201: 101. CrossRef
Real-world evaluation of safety and efficacy of AHCL systems in young children with type 1 diabetes: a 1-year assessment Daniele Franzone, Giordano Spacco, Andrea Piano, Giulia Siri, Giacomo Tantari, Giuseppe d’Annunzio, Maria Grazia Calevo, Mohamad Maghnie, Nicola Minuto, Marta Bassi Frontiers in Endocrinology.2025;[Epub] CrossRef
Artificial Pancreas: The First 20 Years Francis J. Doyle, Boris P. Kovatchev Journal of Diabetes Science and Technology.2025; 19(4): 875. CrossRef
Artificial Pancreas: The First 20 Years* Francis J. Doyle, Boris P. Kovatchev Diabetes Technology & Therapeutics.2025;[Epub] CrossRef
Optimal model-based insulin bolus advisor for subjects with type 1 diabetes using continuous glucose monitoring Martin Dodek, Eva Miklovičová Computers in Biology and Medicine.2025; 196: 110508. CrossRef
Advancements of Glucose Monitoring Biosensor: Current State, Generations of Technological Progress and Innovation Dynamics Arpita Dua, Abhijit Debnath, Kunal Kumar, Rupa Mazumder, Avijit Mazumder, Rajesh Kumar Singh, Saloni Mangal, Jahanvi Sanchitra, Fahad Khan, Soumya Tripathi, Sukriti Vishwas, Hema Chaudhary, Parul Sharma, Shikha Srivastava Current Pharmaceutical Biotechnology.2025; 26(11): 1716. CrossRef
Dual hormone predictive control for a fully automated intraperitoneal artificial pancreas: Preclinical evaluation in pigs Karim Davari Benam, Hasti Khoshamadi, Marte Kierulf Å m, Sverre Chr. Christiansen, Patrick Christian Bösch, Dag Roar Hjelme, Øyvind Stavdahl, Sven Magnus Carlsen, Sébastien Gros, Anders Lyngvi Fougner Journal of Process Control.2025; 154: 103499. CrossRef
Artificial Intelligence in Patient Management Nicholas Conley Primary Care: Clinics in Office Practice.2025; 52(4): 733. CrossRef
Current Status of Continuous Glucose Monitoring Use in South Korean Type 1 Diabetes Mellitus Population–Pronounced Age-Related Disparities: Nationwide Cohort Study Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim Diabetes & Metabolism Journal.2025; 49(5): 1040. CrossRef
Multimodal large language models and mechanistic modeling for glucose forecasting in type 1 diabetes patients J.C. Wolber, M. E. Samadi, J. Sellin, A. Schuppert Journal of Biomedical Informatics.2025; 172: 104945. CrossRef
Effectiveness and safety of automated insulin delivery in type 2 diabetes: a meta-analysis Baoqi Zeng, Hao Jia, Sihan Yang, Jiaming Zheng, Qingqing Yang, Lin Dou Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
The differential impact of automated insulin delivery systems on body mass index in children with type 1 diabetes John Pemberton, Catarina Leal, Anjanee Kohli, Lesley Drummond, Louise Collins, Zainaba Mohamed, Vrinda Saraff, Renuka P. Dias, Melanie Kershaw, Ruth Krone, Suma Uday Journal of Pediatric Endocrinology and Metabolism.2025; 38(12): 1258. CrossRef
Dispositivi indossabili per la gestione del diabete Filippo CARLUCCI, Antonella TABUCCHI, Marcello FIORINI, Lucrezia GALASSO, Alessandro TERRENI Biochimica Clinica.2025;[Epub] CrossRef
Integration of a Safety Module to Prevent Rebound Hypoglycemia in Closed-Loop Artificial Pancreas Systems María F. Villa-Tamayo, Patricio Colmegna, Marc D. Breton Journal of Diabetes Science and Technology.2024; 18(2): 318. CrossRef
The effects of acute hyperglycaemia on sports and exercise performance in type 1 diabetes: A systematic review and meta-analysis Bonar McGuire, Hashim Dadah, Dominic Oliver Journal of Science and Medicine in Sport.2024; 27(2): 78. CrossRef
A new approach to stabilize diabetes systems with time-varying delays and disturbance rejection S. Syafiie, Fahd Alharbi, Abdullah Ali Alshehri, Bassam Hasanain Journal of the Franklin Institute.2024; 361(1): 543. CrossRef
Effects of Low-Dose Glucagon on Subcutaneous Insulin Absorption in Pigs Ingrid Anna Teigen, Marte Kierulf Åm, Misbah Riaz, Sverre Christian Christiansen, Sven Magnus Carlsen Current Therapeutic Research.2024; 100: 100736. CrossRef
Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes John Pemberton, Louise Collins, Lesley Drummond, Renuka P Dias, Ruth Krone, Melanie Kershaw, Suma Uday BMJ Open Diabetes Research & Care.2024; 12(3): e004045. CrossRef
Robust Online Correlation Method for Identification of a Nonparametric Model of Type 1 Diabetes Martin Dodek, Eva Miklovičová IEEE Access.2024; 12: 35899. CrossRef
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial Ji Yoon Kim, Sang-Man Jin, Eun Seok Kang, Soo Heon Kwak, Yeoree Yang, Jee Hee Yoo, Jae Hyun Bae, Jun Sung Moon, Chang Hee Jung, Ji Cheol Bae, Sunghwan Suh, Sun Joon Moon, Sun Ok Song, Suk Chon, Jae Hyeon Kim Diabetologia.2024; 67(7): 1235. CrossRef
Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Maria Luisa Garo, Donatella Pastore, Francesca Pacifici, Camillo Ricordi, David Della-Morte, Marco Infante Metabolism and Target Organ Damage.2024;[Epub] CrossRef
Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions Giulia Bennici, Hanan Almahasheer, Mawadda Alghrably, Daniela Valensin, Arian Kola, Chrysoula Kokotidou, Joanna Lachowicz, Mariusz Jaremko RSC Advances.2024; 14(25): 17448. CrossRef
Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis Qin Yang, Baoqi Zeng, Jiayi Hao, Qingqing Yang, Feng Sun Diabetes, Obesity and Metabolism.2024; 26(9): 3753. CrossRef
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study Marta Bassi, Daniele Franzone, Francesca Dufour, Giordano Spacco, Federico Cresta, Giuseppe d’Annunzio, Giacomo Tantari, Maria Grazia Calevo, Carlo Castellani, Nicola Minuto, Rosaria Casciaro Frontiers in Endocrinology.2024;[Epub] CrossRef
Emerging Technologies in Endocrine Drug Delivery: Innovations for Improved Patient Care Mahvish Renzu, Carly Hubers, Kendall Conway, Viktoriya Gibatova, Vidhi Mehta, Wael Taha Cureus.2024;[Epub] CrossRef
A stochastic model-based control methodology for glycemic management in the intensive care unit Melike Sirlanci, George Hripcsak, Cecilia C. Low Wang, J. N. Stroh, Yanran Wang, Tellen D. Bennett, Andrew M. Stuart, David J. Albers Frontiers in Medical Engineering.2024;[Epub] CrossRef
Advances in Type 1 Diabetes Mellitus Management in Children Mridu Bahal, Vineeta Pande, Jasleen Dua, Shailaja Mane Cureus.2024;[Epub] CrossRef
Expansion of the Pancreas Transplant Recipient Pool: Appropriate for Most or Are There Limits? Jonathan A. Fridell, Robert J. Stratta Current Transplantation Reports.2024; 11(4): 276. CrossRef
Reinforcement Learning: A Paradigm Shift in Personalized Blood Glucose Management for Diabetes Lehel Dénes-Fazakas, László Szilágyi, Levente Kovács, Andrea De Gaetano, György Eigner Biomedicines.2024; 12(9): 2143. CrossRef
Impact of Hypoglycemia on Glucose Variability over Time for Individuals with Open-Source Automated Insulin Delivery Systems Arsalan Shahid, Dana M. Lewis Diabetology.2024; 5(5): 514. CrossRef
Optimal model-based insulin dosing strategy with offline and online optimization Martin Dodek, Eva Miklovičová, Miroslav Halás Informatics in Medicine Unlocked.2024; 51: 101594. CrossRef
Technological advancements in glucose monitoring and artificial pancreas systems for shaping diabetes care Neha Ghosh, Saurabh Verma Current Medical Research and Opinion.2024; 40(12): 2095. CrossRef
A novel pulse-modulated closed-loop artificial pancreas based on intravenous administration of insulin and glucagon Simon L. Goede, Victor H. Snels, Willem-Jan W. J. H. Berghuis, Jan P. C. Bernards, Urs Wyder Scientific Reports.2024;[Epub] CrossRef
100 Years of insulin: A chemical engineering perspective B. Wayne Bequette Korean Journal of Chemical Engineering.2023; 40(1): 1. CrossRef
Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial Sun Joon Moon, Kyung‐Soo Kim, Woo Je Lee, Mi Yeon Lee, Robert Vigersky, Cheol‐Young Park Diabetes, Obesity and Metabolism.2023; 25(1): 110. CrossRef
Identifiable prediction animal model for the bi-hormonal intraperitoneal artificial pancreas Karim Davari Benam, Hasti Khoshamadi, Marte Kierulf Åm, Øyvind Stavdahl, Sebastien Gros, Anders Lyngvi Fougner Journal of Process Control.2023; 121: 13. CrossRef
Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control Jee Hee Yoo, Jae Hyeon Kim Diabetes & Metabolism Journal.2023; 47(1): 27. CrossRef
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review John S Pemberton, Emma G Wilmot, Katharine Barnard‐Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson Diabetes, Obesity and Metabolism.2023; 25(4): 916. CrossRef
Evaluation of awareness and attitude of paediatric nursing students, nurses, and adolescents regarding type one diabetes advanced devices and virtual nursing Howaida Moawad Ahmed Ali Kontakt.2023; 25(2): 100. CrossRef
Predicting the output error of the suboptimal state estimator to improve the performance of the MPC-based artificial pancreas Martin Dodek, Eva Miklovičová Control Theory and Technology.2023; 21(4): 541. CrossRef
A Markov Model of Gap Occurrence in Continuous Glucose Monitoring Data for Realistic in Silico Clinical Trials Martina Vettoretti, Martina Drecogna, Simone Del Favero, Andrea Facchinetti, Giovanni Sparacino Computer Methods and Programs in Biomedicine.2023; 240: 107700. CrossRef
Drug delivery breakthrough technologies – A perspective on clinical and societal impact Beate Bittner, Manuel Sánchez-Félix, Dennis Lee, Athanas Koynov, Joshua Horvath, Felix Schumacher, Simon Matoori Journal of Controlled Release.2023; 360: 335. CrossRef
Importance of continuous glucose monitoring in the treatment of diabetes mellitus Sun Joon Moon, Won-Young Lee Journal of the Korean Medical Association.2023; 66(7): 432. CrossRef
Constrained Versus Unconstrained Model Predictive Control for Artificial Pancreas Chiara Toffanin, Lalo Magni IEEE Transactions on Control Systems Technology.2023; 31(5): 2288. CrossRef
Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up? Valentina Maria Cambuli, Marco Giorgio Baroni International Journal of Molecular Sciences.2023; 24(17): 13139. CrossRef
Artificial Intelligence in Efficient Diabetes Care Gopal Bhagwan Khodve, Sugato Banerjee Current Diabetes Reviews.2023;[Epub] CrossRef
The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control M. K. Åm, I. A. Teigen, M. Riaz, A. L. Fougner, S. C. Christiansen, S. M. Carlsen Journal of Endocrinological Investigation.2023; 47(3): 513. CrossRef
Multivariable Automated Insulin Delivery System for Handling Planned and Spontaneous Physical Activities Mohammad Reza Askari, Mohammad Ahmadasas, Andrew Shahidehpour, Mudassir Rashid, Laurie Quinn, Minsun Park, Ali Cinar Journal of Diabetes Science and Technology.2023; 17(6): 1456. CrossRef
Advanced Technology (Continuous Glucose Monitoring and Advanced Hybrid Closed-Loop Systems) in Diabetes from the Perspective of Gender Differences Maria Grazia Nuzzo, Marciano Schettino Diabetology.2023; 4(4): 519. CrossRef
Artificial Pancreas under a Zone Model Predictive Control based on Gaussian Process models: toward the personalization of the closed loop Marco Polver, Beatrice Sonzogni, Mirko Mazzoleni, Fabio Previdi, Antonio Ferramosca IFAC-PapersOnLine.2023; 56(2): 9642. CrossRef
Personalized Constrained MPC for glucose regulation Chiara Toffanin, Lalo Magni IFAC-PapersOnLine.2023; 56(2): 9648. CrossRef
Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-analysis of Outpatient Randomized Controlled Trials Baoqi Zeng, Le Gao, Qingqing Yang, Hao Jia, Feng Sun Diabetes Care.2023; 46(12): 2300. CrossRef
Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon Frontiers in Endocrinology.2022;[Epub] CrossRef
Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysis Baoqi Zeng, Hao Jia, Le Gao, Qingqing Yang, Kai Yu, Feng Sun Diabetes, Obesity and Metabolism.2022; 24(10): 1967. CrossRef
Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Systematic Review Alezandra Torres-Castaño, Amado Rivero-Santana, Lilisbeth Perestelo-Pérez, Andrea Duarte-Díaz, Analia Abt-Sacks, Vanesa Ramos-García, Yolanda Álvarez-Pérez, Ana M. Wäagner, Mercedes Rigla, Pedro Serrano-Aguilar Applied Sciences.2022; 12(20): 10262. CrossRef
History of insulin treatment of pediatric patients with diabetes in Korea Jae Hyun Kim, Choong Ho Shin, Sei Won Yang Annals of Pediatric Endocrinology & Metabolism.2021; 26(4): 237. CrossRef
Predicting depression severity using machine learning models: Insights from mitochondrial peptides and clinical factors Toheeb Salahudeen, Maher Maalouf, Ibrahim (Abe) M. Elfadel, Herbert F. Jelinek, Ian James Martins PLOS One.2025; 20(5): e0320955. CrossRef
Impact of type 2 diabetes on the risk of cardiovascular disease and cardiovascular mortality in patients with non-alcoholic fatty liver disease: a nationwide population-based study Eun Roh, Han Na Jung, Ji Hye Heo, Kyungdo Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm BMJ Public Health.2025; 3(1): e002020. CrossRef
Recurrent depression relates to worse outcomes than single episode depression among Hispanic adolescents with diabetes Keiliany Rivera-Santiago, Eduardo Cumba-Aviles, Demivette Gómez-Rivera Health Psychology Report.2023;[Epub] CrossRef
Background Previous studies have suggested that depression in patients with diabetes is associated with worse health outcomes. The aim of this study was to evaluate the risk of cardiovascular disease (CVD) and mortality in patients with diabetes with comorbid depression.
Methods We examined the general health check-up data and claim database of the Korean National Health Insurance Service (NHIS) of 2,668,615 participants with type 2 diabetes mellitus who had examinations between 2009 and 2012. As NHIS database has been established since 2002, those who had been diagnosed with depression or CVD since 2002 were excluded. The 2,228,443 participants were classified into three groups according to the claim history of depression; normal group (n=2,166,979), transient depression group (one episode of depression, n=42,124) and persistent depression group (at least two episodes of depression, n=19,340). The development of CVD and mortality were analyzed from 2009 to 2017.
Results Those with depression showed a significantly increased risk for stroke (transient depression group: hazard ratio [HR], 1.20; 95% confidence interval [CI], 1.15 to 1.26) (persistent depression group: HR, 1.54; 95% CI, 1.46 to 1.63). Those with depression had an increased risk for myocardial infarction (transient depression group: HR, 1.25; 95% CI, 1.18 to 1.31) (persistent depression group: HR, 1.38; 95% CI, 1.29 to 1.49). The persistent depression group had an increased risk for all-cause mortality (HR, 1.66; 95% CI, 1.60 to 1.72).
Conclusion Coexisting depression in patients with diabetes has a deleterious effect on the development of CVD and mortality. We suggest that more attention should be given to patients with diabetes who present with depressive symptoms.
Citations
Citations to this article as recorded by
Mental Disorders as a Risk Factor of Acute Coronary Syndrome Arnav Gupta, Tushar Tejpal, Chanhee Seo, Nicholas Fabiano, Selina Zhao, Stanley Wong, Yuan Qiu, Jenna MacNeil, Dain R. Kim, Natasha Aleksova, Sara Siddiqi, Marco Solmi, Jess G. Fiedorowicz JAMA Psychiatry.2026; 83(3): 259. CrossRef
Depression in Type 2 Diabetes: Association with Higher Insulin Resistance and Increased Low Grade Inflammation Jelena Stanarcic Gajovic, Dusica Lecic Tosevski, Katarina Lalic, Tanja Milicic, Ljiljana Lukic, Marija Macesic, Milica Stoiljkovic, Mina Bozic, Djurdja Rafailovic, Nikola Jovanovic, Olivera Vukovic, Sanja Stankovic, Ognjen Milicevic, Stefan Maric, Nina Kr Diabetology.2026; 7(3): 51. CrossRef
Depression severity and cardiovascular risk in patients with type 2 diabetes mellitus: insights from the framingham risk score Soghra Aliasgharzadeh, Neda Lotfi Yagin, Nazli Namazi, Sajjad Haji, Naimeh Mesri Alamdari, Samira Pourmoradian, Ziba Ghorbanverdi, Majid Mobasseri Scientific Reports.2026;[Epub] CrossRef
Antidepressants and Risk of Mortality in People with Depressive Disorder and Co-Occurring Type 2 Diabetes Mellitus: A 20-Year Population-Based Cohort Study Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Francisco Tsz Tsun Lai, Amy Pui Pui Ng, William Chi Wai Wong, Wing Chung Chang Psychotherapy and Psychosomatics.2026; : 1. CrossRef
ЦУКРОВИЙ ДІАБЕТ 2 ТИПУ, НЕЙРОКОГНІТИВНІ РОЗЛАДИ І ОМЕГА-3 ПОЛІНЕНАСИЧЕНІ ЖИРНІ КИСЛОТИ (огляд лiтератури) Олександр Сергієнко, Вероніка Сегін, Віталій Сулима, Вікторія Сергієнко Problems of Endocrine Pathology.2026; 83(1): 52. CrossRef
Association between myocardial infarction and depression: bidirectional links and shared risk pathways—a systematic review and meta-analysis Konstantina-Maria Panoutsopoulou, Nikolaos-Stefanos Bastas, Dimitrios Tsartsalis, Aikaterini Grammeniati, Maria Efstathiou, Mary Gouva, Katerina K Naka, Elena Dragioti European Journal of Preventive Cardiology.2026;[Epub] CrossRef
The Impact of Mental Health Disorders on Mortality Rates in Patients with Type 2 Diabetes Mellitus (Systematic Literature Review) Nadia Putri, Rohman Dakab, Sely Anggraini, Iis Puspitasari, Aprilia Rambe, Reztika Cahyani, Lisa Desi Arimbi, Andang Evrilianto, M. Abdul Hamid Zubair, Sonia Annisa Br Ketaren, Jennifer Irene A. Hadiono, Yuni Kartika, Tuti Alawiyah, Firdaus Firdaus, Noval F1000Research.2026; 15: 753. CrossRef
Antidiabetes agents and risk of incident depression in 686,522 people with type 2 diabetes mellitus: A 20-year population-based cohort study Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Francisco Tsz Tsun Lai, Amy Pui Pui Ng, William Chi Wai Wong, Wing Chung Chang Psychological Medicine.2026;[Epub] CrossRef
Pathomorphological Features of Diabetic Myopathy in Comorbid Conditions Oksana Zhurakivska, Aleksandra Natalia Gabren-Syller, Oleh Koshkin, Viktor Mazurenko, Ivan Paliichuk, Nataliia Pyliachyk Journal of Molecular Pathology.2026; 7(2): 23. CrossRef
Age-dependent association of uric acid levels with depressive symptoms in adults: NHANES 2007–2018 Cong Yao, Guoshuai Luo, Meng Zhang, Yunsheng Fu, Xin Liu, Zonglin Li, Zipeng Chen, Jie Li Journal of Neural Transmission.2026;[Epub] CrossRef
Co-occurring diabetes and depression and their impact on CVD, CAD, and stroke risk over a 10-year follow-up: A cohort study Hossein Ghazaee, Vahid Mahdavizadeh, Ali Rezaee, Susan Darroudi, Mohsen Rezaee, Habibollah Esmaily, Mohsen Mehrabzadeh, Hediye Erfaniyan Shahabi, Hoda Sabbagh Sajadiyeh, Reihaneh Alizadeh, Majid Ghayour-Mobarhan, Zahra Mazloum Khorasani Journal of Diabetes & Metabolic Disorders.2026;[Epub] CrossRef
Risk of mortality and complications in people with depressive disorder and co-occurring diabetes mellitus: a systematic review and meta-analysis Matthew Tsz Ho Ho, Kwun Nam Chan, Will Chi Yuen Chiu, Lucy Lo Wah Tsang, Heidi Ka Ying Lo, Steven Yiu Long Wong, Kenneth Shut Wah Chan, Mimi Mei Cheung Wong, Ho Hon Wong, Wai Chung Lam, Pui Fai Pang, Wing Chung Chang Epidemiology and Psychiatric Sciences.2026;[Epub] CrossRef
Risk of mortality and complications in people with depressive disorder and diabetes mellitus: A 20-year population-based propensity score-matched cohort study Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Francisco Tsz Tsun Lai, Amy Pui Pui Ng, Ken Qingqi Chen, William Chi Wai Wong, Wing Chung Chang European Neuropsychopharmacology.2025; 92: 10. CrossRef
Epidemiological insights into chronic urticaria, vitiligo, alopecia areata, and herpes zoster following COVID‐19 infection: A nationwide population‐based study Min Hee Kim The Journal of Dermatology.2025; 52(3): 499. CrossRef
The association between C-reactive protein-albumin-lymphocyte index and depression in adults with type 2 diabetes mellitus: A cross-sectional study from NHANES Wei Hu, Qian Yuan, Jie Hu, Mingzi Li, Yue Xi, Ling Luo Psychoneuroendocrinology.2025; 176: 107442. CrossRef
Type 2 diabetes mellitus, cerebral small vessel disease and depressive disorders V.A. Serhiyenkо, O.M. Chemerys, V.I. Pankiv, A.A. Serhiyenko INTERNATIONAL NEUROLOGICAL JOURNAL.2025; 21(3): 226. CrossRef
The neutrophil percentage-to-albumin ratio mediates the association between depression and all-cause mortality in U.S. adults: Evidence from NHANES 2009–2018 Kunxiu Wang, Gaofeng Liu, Yuchen Pan, Siyu Li, Xiaoling Zhu, Hui Qu, Xuesong Liang, Song Chen, Wenbin Fu Journal of Affective Disorders.2025; 389: 119736. CrossRef
Healthcare resource utilization of people with depressive disorder and co-occurring incident diabetes mellitus: A 20-year population-based propensity score-matched cohort study Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Wing Chung Chang General Hospital Psychiatry.2025; 96: 244. CrossRef
Prevalence and risk factors of depression in middle-aged and elderly women with diabetes: a protocol of systematic review and meta-analysis Yiting Pan, Longhan Zhang, An Luo, Yaqing Liu, Hao Bai, Lingqiao Song, Zeyuan Long, Li Liao BMJ Open.2025; 15(10): e104902. CrossRef
The Bidirectional Relationship Between Myocardial Infarction and Depression: Risk Factors, Mechanisms, and Interventions Zhuorui Cui, Qiaoning Yang, Furong Yang, Yankai Yang, Xuexin Yang, Yanqiao Yu, Yajie Cai, Xiaodi Fan, Ruina Bai Biomedicines.2025; 13(11): 2838. CrossRef
Psychological resilience mediates the relationship between diabetes distress and depression among persons with diabetes in a multi-group analysis Ajele Kenni Wojujutari, Erhabor Sunday Idemudia, Lawrence Ejike Ugwu Scientific Reports.2024;[Epub] CrossRef
CVD incidence and mortality among people with diabetes and/or hypertension: Results from the English longitudinal study of ageing Paola Zaninotto, Andrew Steptoe, Eun-Jung Shim, Attila Csaba Nagy PLOS ONE.2024; 19(5): e0303306. CrossRef
Impact of mental disorders on the all-cause mortality and cardiovascular disease outcomes in adults with new-onset type 1 diabetes: A nationwide cohort study Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim Psychiatry Research.2024; 342: 116228. CrossRef
Individual and joint effects of diabetes and depression on incident cardiovascular diseases and all-cause mortality: Results from a population-based cohort study Qiang Tu, Karice Hyun, Shuanglan Lin, Nashid Hafiz, Deborah Manandi, Qian Zhang, Xinzheng Wang, Na Zhang, Haisheng Wu, Julie Redfern Journal of Diabetes and its Complications.2024; 38(11): 108878. CrossRef
A Nationwide Population-Based Study for Audio-Vestibular Disorders following COVID-19 Infection Hye Yeon Ko, Min Hee Kim Audiology and Neurotology.2024; 30(3): 245. CrossRef
The mediating effect of depression on new-onset stroke in diabetic population: Evidence from the China health and retirement longitudinal study Gege Jiang, Yaoling Wang, Liping Wang, Minfang Chen, Wei Li Journal of Affective Disorders.2023; 321: 208. CrossRef
Frailty and outcomes in lacunar stroke Sima Vazquez, Zehavya Stadlan, Justin M Lapow, Eric Feldstein, Smit Shah, Ankita Das, Alexandria F Naftchi, Eris Spirollari, Akash Thaker, Syed Faraz Kazim, Jose F Dominguez, Neisha Patel, Christeena Kurian, Ji Chong, Stephan A Mayer, Gurmeen Kaur, Chirag Journal of Stroke and Cerebrovascular Diseases.2023; 32(2): 106942. CrossRef
Comparison of Operational Definition of Type 2 Diabetes Mellitus Based on Data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey Jong Ha Baek, Yong-Moon Park, Kyung Do Han, Min Kyong Moon, Jong Han Choi, Seung-Hyun Ko Diabetes & Metabolism Journal.2023; 47(2): 201. CrossRef
The Association between Dietary Carotenoid Intake and Risk of Depression among Patients with Cardiometabolic Disease Jie Liang, Yuhao Wang, Min Chen International Heart Journal.2023; 64(2): 223. CrossRef
Associations of concomitant retinopathy and depression with mortality in a nationally representative population Zheng Lyu, Yilin Chen, Zhuoting Zhu, Xiaoyang Luo, Ying Cui, Jie Xie, Zhifan Chen, Junbin Liu, Xiyu Wu, Gabrella Bulloch, Qianli Meng Journal of Affective Disorders.2023; 336: 15. CrossRef
Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses Chiara Possidente, Giuseppe Fanelli, Alessandro Serretti, Chiara Fabbri Neuroscience & Biobehavioral Reviews.2023; 152: 105298. CrossRef
Prevalence of depression and association with all-cause and cardiovascular mortality among individuals with type 2 diabetes: a cohort study based on NHANES 2005–2018 data Zhen Feng, Wai Kei Tong, Xinyue Zhang, Zhijia Tang BMC Psychiatry.2023;[Epub] CrossRef
Cholecystectomy Increases the Risk of Type 2 Diabetes in the Korean Population Ji Hye Huh, Kyong Joo Lee, Yun Kyung Cho, Shinje Moon, Yoon Jung Kim, Eun Roh, Kyung-do Han, Dong Hee Koh, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm Annals of Surgery.2023; 278(2): e264. CrossRef
Risk of depression in patients with acromegaly in Korea (2006-2016): a nationwide population-based study Shinje Moon, Sangmo Hong, Kyungdo Han, Cheol-Young Park European Journal of Endocrinology.2023; 189(3): 363. CrossRef
The association between cardiovascular drugs and depression/anxiety in patients with cardiovascular disease: A meta-analysis Lijun Zhang, Yanping Bao, Shuhui Tao, Yimiao Zhao, Meiyan Liu Pharmacological Research.2022; 175: 106024. CrossRef
Association of mental health with the risk of coronary artery disease in patients with diabetes: A mendelian randomization study Teng Hu, Fangkun Yang, Kewan He, Jiajun Ying, Hanbin Cui Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(3): 703. CrossRef
Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease Mengmeng Zhu, Yiwen Li, Binyu Luo, Jing Cui, Yanfei Liu, Yue Liu Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research Dae-Sung Kyoung, Hun-Sung Kim Journal of Lipid and Atherosclerosis.2022; 11(2): 103. CrossRef
Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality Kyung-Soo Kim, Sangmo Hong, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park Journal of General Internal Medicine.2022; 37(16): 4153. CrossRef
Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats Himanshu Verma, Anindita Bhattacharjee, Naveen Shivavedi, Prasanta Kumar Nayak Naunyn-Schmiedeberg's Archives of Pharmacology.2022; 395(10): 1189. CrossRef
Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Kun-Ho Yoon, Seung-Hwan Lee European Journal of Preventive Cardiology.2022; 29(14): 1866. CrossRef
Risk factors associated with mortality among individuals with type 2 diabetes and depression across two cohorts Christopher Rohde, Jens Steen Nielsen, Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Søren Dinesen Østergaard European Journal of Endocrinology.2022; 187(4): 567. CrossRef
Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89) Jin Hwa Kim Diabetes & Metabolism Journal.2021; 45(5): 789. CrossRef
Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89) Inha Jung, Eun-Jung Rhee, Won-Young Lee Diabetes & Metabolism Journal.2021; 45(5): 793. CrossRef
Affective Temperament and Glycemic Control – The Psychological Aspect of Obesity and Diabetes Mellitus Natalia Lesiewska, Anna Kamińska, Roman Junik, Magdalena Michalewicz, Bartłomiej Myszkowski, Alina Borkowska, Maciej Bieliński Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 4981. CrossRef